Abstract
The clinical relevance of newly described nontuberculous mycobacteria is often unclear. We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had chronic obstructive pulmonary disease. Antimicrobial drug susceptibility testing showed low MICs for macro-lides, aminoglycosides, fluoroquinolones, tetracyclines, imipenem, and linezolid.
Cite
CITATION STYLE
Salzer, H. J. F., Chitechi, B., Hillemann, D., Mandl, M., Paar, C., Mitterhumer, M., … Maurer, F. P. (2020). Nontuberculous mycobacterial pulmonary disease from mycobacterium hassiacum, Austria. Emerging Infectious Diseases, 26(11), 2776–2778. https://doi.org/10.3201/eid2611.191718
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.